StreetInsider.com News Articles

RVNC DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Tue, 04 Mar 2025 18:39:00 -0500

New York, New York--(Newsfile Corp. - March 4, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"), of the important March 4, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Tue, 04 Mar 2025 18:39:00 -0500

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Tue, 04 Mar 2025 16:00:00 -0500

New York, New York--(Newsfile Corp. - March 4, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ: RVNC) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the

RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Tue, 04 Mar 2025 16:00:00 -0500

Class Definition

RVNC DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Mon, 03 Mar 2025 18:34:00 -0500

New York, New York--(Newsfile Corp. - March 3, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"), of the important March 4, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Mon, 03 Mar 2025 18:34:00 -0500

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mon, 03 Mar 2025 16:00:00 -0500

New York, New York--(Newsfile Corp. - March 3, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ: RVNC) and certain of its officers.

Class Definition

RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mon, 03 Mar 2025 16:00:00 -0500

Class Definition

RVNC DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Sun, 02 Mar 2025 13:24:00 -0500

New York, New York--(Newsfile Corp. - March 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"), of the important March 4, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Sun, 02 Mar 2025 13:24:00 -0500

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call

RVNC DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Sat, 01 Mar 2025 13:24:00 -0500

New York, New York--(Newsfile Corp. - March 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"), of the important March 4, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call Phillip

RVNC DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Sat, 01 Mar 2025 13:24:00 -0500

SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Revance class action, go to https://rosenlegal.com/submit-form/?case_id=36048 or call Phillip

Form 15-12G Revance Therapeutics,

Tue, 18 Feb 2025 06:11:00 -0500

si-local-file:///var/storage/secattach/20250218/24360104.html

Form 15-12G Revance Therapeutics,

Tue, 18 Feb 2025 06:11:00 -0500

si-local-file:///var/storage/secattach/20250218/24360104.html

Form SCHEDULE 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP

Thu, 13 Feb 2025 16:03:00 -0500

si-local-file:///var/storage/secattach/20250213/24344567.html

Form SCHEDULE 13G/A Revance Therapeutics, Filed by: Palo Alto Investors LP

Thu, 13 Feb 2025 16:03:00 -0500

si-local-file:///var/storage/secattach/20250213/24344567.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:16:00 -0500

si-local-file:///var/storage/secattach/20250212/24332828.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:16:00 -0500

si-local-file:///var/storage/secattach/20250212/24332828.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:08:00 -0500

si-local-file:///var/storage/secattach/20250212/24332792.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:08:00 -0500

si-local-file:///var/storage/secattach/20250212/24332792.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:07:00 -0500

si-local-file:///var/storage/secattach/20250212/24332787.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:07:00 -0500

si-local-file:///var/storage/secattach/20250212/24332787.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:05:00 -0500

si-local-file:///var/storage/secattach/20250212/24332768.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:05:00 -0500

si-local-file:///var/storage/secattach/20250212/24332768.html

Form S-8 POS Revance Therapeutics,

Wed, 12 Feb 2025 08:04:00 -0500

si-local-file:///var/storage/secattach/20250212/24332749.html